Clinical Trials Browser

Phase 2/3 × Mouth Neoplasms × pembrolizumab × Clear all

NCT06295731 2025-11-17

HexAgon-HN

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms